Bloomberg reports unregulated nootropic peptides like Semax spreading among biohackers
A Los Angeles user who tapered off Adderall after nearly two decades describes switching to a Russian nasal-spray peptide for focus and brain fog.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 8 05:15 ETSource: Bloomberg.com
The wire
- 01Bloomberg profiles 44-year-old Taylor Bauer, who says he turned to Semax nasal spray around 2023 after tapering off Adderall because of mental and physical side effects.
- 02Cognitive peptides sold outside approval channels are drawing users away from prescribed psychiatric medication, a pattern clinicians and pharmacists are likely to encounter.
- 03The report describes Semax as largely unproven, and the account is one user's subjective experience rather than clinical evidence.
From the source
Read at bloomberg.comThe Brain Is the Next Frontier for Unregulated Peptides
Taylor Bauer is a 44-year-old self-proclaimed biohacker in Los Angeles. He decided to taper off Adderall around 2023, after nearly two decades, when he experienced mental and physical side effects. Instead of another form of psychiatric medication, Bauer turned toward an unlikely — and largely unproven — candidate to help with his brain fog and focus: a Russian peptide called Semax.
